A Form 4 filed with the SEC on August 12, 2026 discloses that Mark Christopher Murray, Senior Vice President of Acetyls at Celanese Corp, purchased 2,153 shares of common stock on August 11, 2026.
Key Highlights
- Reporting person: Mark Christopher Murray, SVP - Acetyls at Celanese Corp
- Transaction: Purchase (transaction code P) of 2,153 shares of common stock on August 11, 2026
- Price per share: $45.5199
- Post-transaction ownership: 30,432 shares of common stock held directly
- Filing date: August 12, 2026, signed by Christine Dryden as Attorney-in-Fact
Celanese SVP - Acetyls Purchases Shares in Open Market Transaction
According to the Form 4 filed with the SEC, Mark Christopher Murray, an officer of Celanese Corp (NYSE:CE) holding the title SVP - Acetyls, acquired 2,153 shares of Celanese common stock on August 11, 2026. The transaction was recorded under transaction code P, indicating an open market purchase, at a price of $45.5199 per share. The shares were acquired directly.
Following the reported purchase, the filing indicates that Murray beneficially owns 30,432 shares of Celanese common stock on a direct basis. No derivative securities were reported in Table II of the filing. The Form 4 was filed as an individual filing by one reporting person and was signed on August 12, 2026 by Christine Dryden as Attorney-in-Fact for Mark Christopher Murray.
What Was Disclosed
The filing reports a single open market purchase of 2,153 shares of Celanese Corp common stock by SVP - Acetyls Mark Christopher Murray on August 11, 2026, at $45.5199 per share, resulting in direct beneficial ownership of 30,432 shares.




Please wait processing your request...